MARKET

DXR

DXR

DAXOR CORP
NASDAQ
13.40
-0.23
-1.69%
After Hours: 13.12 -0.28 -2.09% 18:13 10/04 EDT
OPEN
13.98
PREV CLOSE
13.63
HIGH
14.20
LOW
13.40
VOLUME
9.25K
TURNOVER
0
52 WEEK HIGH
14.55
52 WEEK LOW
9.52
MARKET CAP
54.16M
P/E (TTM)
12.07
1D
5D
1M
3M
1Y
5Y
Study Data From Mayo Clinic On Heart Failure Treatment Effectiveness Utilizing Daxor BVA-100 Presented At Key Scientific Meeting On October 2nd; More Than 50% Discharged From Hospital With Suboptimal Treatment
Traditional Care: More than 50% Discharged From Hospital With Suboptimal Treatment Oak Ridge, TN, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in
Benzinga · 18h ago
BRIEF-Daxor Corp - New Data Validating Benefits Of Company's Bva-100 Diagnostic Blood Test
BRIEF-Daxor Corp - New Data Validating Benefits Of Company's Bva-100 Diagnostic Blood Test
Reuters · 1d ago
BRIEF-New Data Shows 85% Reduction In One-Year Mortality For Medicare Heart Failure Patients With Bva-Guided Care
BRIEF-New Data Shows 85% Reduction In One-Year Mortality For Medicare Heart Failure Patients With Bva-Guided Care
Reuters · 1d ago
New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100® Lowers Hospital Length of Stay by 55%
Patients Receiving BVA Stayed 2.5 Fewer Days in Hospital Resulting in Reduced Costs of Care Oak Ridge, TN, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation, the global leader in blood volume measurement technology, today announces new data validating th...
GlobeNewswire · 1d ago
New Studies Validating The Uniqueness Of The BVA-100 Blood Test For Heart Failure Patients Compared To Pressure Measures; Shows 85% Reduction In One-Year Mortality For Medicare Heart Failure Patients With BVA-Guided Care
Patient One-Year Mortality Rate 5.6% with BVA-Guided Care Compared to 36.8% in Control Group - Data Presented at Key Scientific Meeting Oak Ridge, TN, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Daxor
Benzinga · 1d ago
BRIEF-Daxor Co Announces New Data From Duke Heart Validating Benefits Of Co's Bva-100 Blood Test In Optimizing Individualized Therapy For Heart Failure Patients
BRIEF-Daxor Co Announces New Data From Duke Heart Validating Benefits Of Co's Bva-100 Blood Test In Optimizing Individualized Therapy For Heart Failure Patients
Reuters · 1d ago
New Studies Validating the Uniqueness of the BVA-100® Blood Test for Heart Failure Patients Compared to Pressure Measures
Presented at Key Scientific Society Meeting -Commonly Used Pressure Measures for Volume Assessment Proven Not Equivalent to BVA Oak Ridge, TN, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement te...
GlobeNewswire · 1d ago
Daxor Corporation to Exhibit at the Annual Scientific Meeting of the Heart Failure Society of America
Compelling New Patient Outcome Data to be Presented Oak Ridge, TN, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be attending the Annual Scientific Meet...
GlobeNewswire · 09/26 12:00
More
About DXR
Daxor Corporation is a medical instrumentation and biotechnology company. The Company is focused on blood volume measurement. The Company has developed and marketed the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the food and drug administration (FDA) to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 60,000+ tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a broad range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. It has ongoing multicenter trials in the areas of COVID-19 and heart failure treatment with support from the National Institutes of Health (NIH) and is under contract developing analyzers.

Webull offers kinds of Daxor Corporation stock information, including NASDAQ:DXR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DXR stock methods without spending real money on the virtual paper trading platform.